000 | 01365 a2200361 4500 | ||
---|---|---|---|
005 | 20250511211825.0 | ||
264 | 0 | _c19911017 | |
008 | 199110s 0 0 eng d | ||
022 | _a0002-9645 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMitchell, D H | |
245 | 0 | 0 |
_aCytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors. _h[electronic resource] |
260 |
_bAmerican journal of veterinary research _cJul 1991 |
||
300 |
_a1132-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xtherapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 |
_aDog Diseases _xtherapy |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aImmunotherapy, Adoptive |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
650 | 0 | 4 |
_aLymphocytes _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteosarcoma _xsecondary |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
700 | 1 | _aWithrow, S J | |
700 | 1 | _aJohnston, M R | |
700 | 1 | _aKruse, C A | |
773 | 0 |
_tAmerican journal of veterinary research _gvol. 52 _gno. 7 _gp. 1132-6 |
|
999 |
_c1898469 _d1898469 |